Predict your next investment

Medical Ingenuities company logo
HEALTHCARE | Medical Devices & Equipment / Patient Monitoring
medicalingenuities.com

See what CB Insights has to offer

Total Raised

$990K

Investors Count

2

Medical Ingenuities Funding, Medical Ingenuities Valuation & Medical Ingenuities Revenue

2 Fundings

Medical Ingenuities's latest funding round was a Seed VC - II for $0.99M on January 27, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/27/2021

Seed VC - II

$0.99M

Genesis Innovation Group, and Undisclosed Investors

$0.00B

((9.99x))

FY 1234

2

11/20/2018

Seed VC

$99M

$0.00B

((9.99x))

FY 1234

10

Date

1/27/2021

11/20/2018

Round

Seed VC - II

Seed VC

Amount

$0.99M

$99M

Investors

Genesis Innovation Group, and Undisclosed Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

2

10

Medical Ingenuities Investors

2 Investors

Medical Ingenuities has 2 investors. Genesis Innovation Group invested in Medical Ingenuities's Seed VC - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/27/2021

1/27/2021

1
Seed VC - II

Venture Capital

Michigan

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Corporate Venture

Michigan

First funding

1/27/2021

00/00/0000

Last Funding

1/27/2021

00/00/0000

Investor

Subscribe to see more

Rounds

1
Seed VC - II

Subscribe to see more

Board Seats

Subscribe to see more

Type

Venture Capital

Corporate Venture

Location

Michigan

Michigan

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.